Application deadline is July 9, 2025
COLUMBIA, Md., June 4, 2025 /PRNewswire/ — The Maryland Stem Cell Research Commission (“Commission“) is pleased to announce the release of Requests for Applications (RFAs) for the July 2025 funding cycle. The deadline for application submissions is July 9, 2025.
The upcoming cycle supports a broad spectrum of grant programs, including early-stage basic research, translational efforts, clinical trials and manufacturing support. Maryland-based academic institutions, nonprofits and companies are encouraged to apply. Additionally, companies/non-profit entities outside Maryland are eligible to apply, provided the funded research occurs within the state. Supplemental funding is available for research projects involving collaboration between public and private sectors, accelerating the development of therapies for unmet medical needs.
“Despite ongoing uncertainties in federal funding, Maryland Stem Cell Research Fund (MSCRF) remains unwavering in its commitment to support Maryland’s pioneering stem cell scientists and companies. Our dedication to advancing innovative therapies continues undeterred, and we are grateful for the steadfast support from Maryland Governor Moore’s administration and the General Assembly to help us succeed in this critical mission,” said Ruchika Nijhara, Ph.D., executive director of MSCRF.
“These funding opportunities are another big step in helping Maryland lead the way in stem cell and regenerative medicine research. Investing in innovative science and encouraging collaboration will open the door to life-changing therapies and help Maryland’s biotech community thrive in a way that benefits everyone,” said Rachel Brewster, Ph.D., chair of the Commission.
To date, MSCRF has supported over 700 research projects, investing over $230 million. In May 2025 alone, over $18 million was allocated to 52 projects spanning all stages of technology development, from basic research to clinical application and manufacturing.
Key Dates:
For full details on RFAs and application instructions, visit www.mscrf.org. For questions or assistance, contact mscrfinfo@tedcomd.com.
MSCRF remains committed to advancing innovative research, supporting economic growth and positioning Maryland as a premier hub for regenerative medicine.
About the Maryland Stem Cell Research Commission and Maryland Stem Cell Research Fund
The Maryland Stem Cell Research Commission, through Maryland Stem Cell Research Fund, focuses on identifying and funding cutting-edge research and innovation in the field of regenerative medicine in Maryland. Our Accelerating Cures initiative comprises programs that help transition human stem cell-based technologies from the bench to the bedside as well as mechanisms to build and grow stem cell companies in Maryland.
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contact
Tammi Thomas, Chief Development & Marketing Officer, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com
SOURCE Maryland Stem Cell Research Commission
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…